Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

GreenLight Biosciences Holdings, PBC (Nasdaq: GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.
byCharles Gross
January 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Archer-Daniels-Midland, B. Riley Financial And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

By Avi Kapoor
January 22, 6:07 AM
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Archer-Daniels-Midland Company (NYSE: ADM) fell sharply in today’s pre-market trading after the company named Ismael Roig as Interim Chief Financial Officer.

ADM